Harpoon Shareholder Sues For Records On $680M Merck Buy
By Leslie A. Pappas · March 7, 2024, 6:58 PM EST
A shareholder of Harpoon Therapeutics Inc. sued in Delaware's Court of Chancery Thursday for corporate documents related to the company's proposed $680 million cash buyout by Merck, saying the proposed deal...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login